Interview series showcases insights from authors on molecular targets in CHARGE syndrome, highlighting implications for therapy.
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Melody Hancock is first author on ‘ Multi-omic analyses identify molecular targets of Chd7 that contribute to CHARGE syndrome model phenotypes’, published in DMM. Melody is a PhD candidate in the lab of Kurt Marsden at North Carolina State University, Raleigh, NC, USA, investigating the mechanisms that mediate genetic disease pathogenesis by integrating next-generation sequencing (NGS) datasets to aid therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: